[HTML][HTML] Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
M Zhang, W Hu, C Cai, Y Wu, J Li, S Dong - Materials Today Bio, 2022 - Elsevier
Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …
Nanomedical approaches in the realm of rheumatoid arthritis
Rheumatoid arthritis (RA) is a heterogeneous autoimmune inflammatory disorder defined by
the damage to the bone and cartilage in the synovium, which causes joint impairment and …
the damage to the bone and cartilage in the synovium, which causes joint impairment and …
Microenvironment-responsive nanocarriers for targeted bone disease therapy
M Li, B Yu, S Wang, F Zhou, J Cui, J Su - Nano Today, 2023 - Elsevier
Nanomedicines with controlled drug release have received increasing attention as an
advanced therapeutic strategy for bone diseases. To traverse biological barriers towards …
advanced therapeutic strategy for bone diseases. To traverse biological barriers towards …
[HTML][HTML] “Smart” stimuli-responsive biomaterials revolutionizing the theranostic landscape of inflammatory arthritis
Inflammatory arthritis is a growing worldwide concern, afflicting millions of individuals and
leading to a depreciating quality of life, significant morbidity, and subsequent healthcare …
leading to a depreciating quality of life, significant morbidity, and subsequent healthcare …
Bioresponsive immunotherapeutic materials
The human immune system is an interaction network of biological processes, and its
dysfunction is closely associated with a wide array of diseases, such as cancer, infectious …
dysfunction is closely associated with a wide array of diseases, such as cancer, infectious …
Active targeted nanoformulations via folate receptors: State of the art and future perspectives
C Martín-Sabroso, AI Torres-Suárez… - Pharmaceutics, 2021 - mdpi.com
In normal tissues, the expression of folate receptors is low and limited to cells that are
important for embryonic development or for folate reabsorption. However, in several …
important for embryonic development or for folate reabsorption. However, in several …
Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA), an autoimmune inflammatory disorder is currently incurable.
Methotrexate and Teriflunomide are routinely prescribed drugs but their uses are limited due …
Methotrexate and Teriflunomide are routinely prescribed drugs but their uses are limited due …
Nanomaterials manipulate macrophages for rheumatoid arthritis treatment
S Li, J Su, W Cai, J Liu - Frontiers in Pharmacology, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic, progressive, and systemic inflammatory autoimmune
disease, characterized by synovial inflammation, synovial lining hyperplasia and …
disease, characterized by synovial inflammation, synovial lining hyperplasia and …
Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan‐Based Nanocarriers
Chitosan‐based nanocarriers (ChNCs) are considered suitable drug carriers due to their
ability to encapsulate a variety of drugs and cross biological barriers to deliver the cargo to …
ability to encapsulate a variety of drugs and cross biological barriers to deliver the cargo to …
Glycol chitosan stabilized nanomedicine of lapatinib and doxorubicin for the management of metastatic breast tumor
Advanced breast cancer is known to be highly evasive to conventional therapeutic regimes
with a 5-year survival rate of less than 30% compared to over 90% for early stages. Although …
with a 5-year survival rate of less than 30% compared to over 90% for early stages. Although …